Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 1/2015

Open Access 01-12-2015 | Research

Effect of high-dose dexamethasone on perioperative lactate levels and glucose control: a randomized controlled trial

Authors: Thomas H Ottens, Maarten WN Nijsten, Jan Hofland, Jan M Dieleman, Miriam Hoekstra, Diederik van Dijk, Joost MAA van der Maaten

Published in: Critical Care | Issue 1/2015

Login to get access

Abstract

Introduction

Blood lactate levels are increasingly used to monitor patients. Steroids are frequently administered to critically ill patients. However, the effect of steroids on lactate levels has not been adequately investigated. We studied the effect of a single intraoperative high dose of dexamethasone on lactate and glucose levels in patients undergoing cardiac surgery.

Methods

The Dexamethasone for Cardiac Surgery (DECS) trial was a multicenter randomized trial on the effect of dexamethasone 1 mg/kg versus placebo on clinical outcomes after cardiac surgery in adults. Here we report a pre-planned secondary analysis of data from DECS trial participants included at the University Medical Center Groningen. The use of a computer-assisted glucose regulation protocol—Glucose Regulation for Intensive care Patients (GRIP)—was part of routine postoperative care. GRIP aimed at glucose levels of 4 to 8 mmol/L. Primary outcome parameters were area under the lactate and glucose curves over the first 15 hours of ICU stay (AUC15). ICU length of stay and mortality were observed as well.

Results

The primary outcome could be determined in 497 patients of the 500 included patients. During the first 15 hours of ICU stay, lactate and glucose levels were significantly higher in the dexamethasone group than in the placebo group: lactate AUC15 25.8 (13.1) versus 19.9 (11.2) mmol/L × hour, P <0.001 and glucose AUC15 126.5 (13.0) versus 114.4 (13.9) mmol/L × hour, P <0.001. In this period, patients in the dexamethasone group required twice as much insulin compared with patients who had received placebo. Multivariate and cross-correlation analyses suggest that the effect of dexamethasone on lactate levels is related to preceding increased glucose levels. Patients in the placebo group were more likely to stay in the ICU for more than 24 hours (39.2%) compared with patients in the dexamethasone group (25.0%, P = 0.001), and 30-day mortality rates were 1.6% and 2.4%, respectively (P = 0.759).

Conclusions

Intraoperative high-dose dexamethasone increased postoperative lactate and glucose levels in the first 15 hours of ICU stay. Still, patients in the dexamethasone group had a shorter ICU length of stay and similar mortality compared with controls.

Trial registration

ClinicalTrials.gov NCT00293592. Registered 16 February 2006.
Appendix
Available only for authorised users
Literature
1.
Dieleman JM, van Paassen J, Van Dijk D, Arbous MS, Kalkman CJ, Vandenbroucke JP, et al. Prophylactic corticosteroids for cardiopulmonary bypass in adults. Cochrane Database Syst Rev. 2011;5:CD005566.
2.
Whitlock RP, Chan S, Devereaux PJ, Sun J, Rubens FD, Thorlund K, et al. Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials. Eur Heart J. 2008;29:2592–600.CrossRef
3.
Dieleman JM, Nierich AP, Rosseel PM, van der Maaten JM, Hofland J, Diephuis JC, et al. Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. JAMA. 2012;308:1761–7.CrossRef
4.
Cappabianca G, Rotunno C, de Luca Tupputi Schinosa L, Ranieri VM, Paparella D. Protective Effects of Steroids in Cardiac Surgery: A Meta-Analysis of Randomized Double-Blind Trials. J Cardiothorac Vasc Anesth. 2011;25:156–65.CrossRef
5.
Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359–67.CrossRef
6.
NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–97.CrossRef
7.
Kilger E, Weis F, Briegel J, Frey L, Goetz AE, Reuter D, et al. Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med. 2003;31:1068–74.CrossRef
8.
Mayumi H, Zhang QW, Nakashima A, Masuda M, Kohno H, Kawachi Y, et al. Synergistic immunosuppression caused by high-dose methylprednisolone and cardiopulmonary bypass. Ann Thorac Surg. 1997;63:129–37.CrossRef
9.
Taylor DJ, Faragher EB, Evanson JM. Inflammatory cytokines stimulate glucose uptake and glycolysis but reduce glucose oxidation in human dermal fibroblasts in vitro. Circ Shock. 1992;37:105–10.PubMed
10.
Wurtman RJ, Axelrod J. Control of enzymatic synthesis of adrenaline in the adrenal medulla by adrenal cortical steroids. J Biol Chem. 1966;25(241):2301–5.CrossRef
11.
Luchette FA, Friend LA, Brown CC, Upputuri RK, James JH. Increased skeletal muscle Na+, K + -ATPase activity as a cause of increased lactate production after hemorrhagic shock. J Trauma. 1998;44:796–803.CrossRef
12.
Landow L. Splanchnic lactate production in cardiac surgery patients. Crit Care Med. 1993;21:S84–91.CrossRef
13.
Maerz LL, Akhtar S. Perioperative glycemic management in 2011: paradigm shifts. Curr Opin Crit Care. 2011;17:370–5.PubMed
14.
Akhtar S, Barash PG, Inzucchi SE. Scientific principles and clinical implications of perioperative glucose regulation and control. Anesth Analg. 2010;110:478–97.CrossRef
15.
Bakker J, Nijsten M, Jansen TC. Clinical use of lactate monitoring in critically ill patients. Ann Intensive Care. 2013;10:12.CrossRef
16.
Maillet J-M, Le Besnerais P, Cantoni M, Nataf P, Ruffenach A, Lessana A, et al. Frequency, risk factors, and outcome of hyperlactatemia after cardiac surgery. Chest. 2003;123:1361–6.CrossRef
17.
Abramson D, Scalea TM, Hitchcock R, Trooskin SZ, Henry SM, Greenspan J. Lactate clearance and survival following injury. J Trauma. 1993;35:584–9.CrossRef
18.
Bakker J, Gris P, Coffernils M, Kahn RJ, Vincent JL. Serial blood lactate levels can predict the development of multiple organ failure following septic shock. Am J Surg. 1996;171:221–6.CrossRef
19.
Jansen TC, Van Bommel J, Woodward R, Mulder PG, Bakker J. Association between blood lactate levels, Sequential Organ Failure Assessment subscores, and 28-day mortality during early and late intensive care unit stay: a retrospective observational study. Crit Care Med. 2009;37:2369–74.CrossRef
20.
McNelis J, Marini C, Jurkiewicz A, Szomstein S, Simms H, Ritter G, et al. Prolonged lactate clearance is associated with increased mortality in the surgical intensive care unit. Am J Surg. 2001;182:481–5.CrossRef
21.
Vogelzang M, Zijlstra F, Nijsten MW. Design and implementation of GRIP: a computerized glucose control system at a surgical intensive care unit. BMC Med Inform Decis Mak. 2005;5:38.CrossRef
22.
Vogelzang M, Loef BG, Regtien JG, Van der Horst IC, Van Assen H, Zijlstra F, et al. Computer-assisted glucose control in critically ill patients. Intensive Care Med. 2008;34:1421–7.CrossRef
23.
Vogelzang M, Van der Horst IC, Nijsten MW. Hyperglycaemic index as a tool to assess glucose control: a retrospective study. Crit Care. 2004;8:R122–7.CrossRef
24.
Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16:9–13.CrossRef
25.
Jansen TC, Van Bommel J, Schoonderbeek FJ, Visser SJ, van der Klooster JM, Lima AP, et al. Early Lactate-Guided Therapy in Intensive Care Unit Patients. Am J Respir Crit Care Med. 2010;182:752–61.CrossRef
26.
Annane D, Bellissant E, Bollaert P-E, Briegel J, Confalonieri M, De Gaudio R, et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA. 2009;301:2362–75.CrossRef
27.
El-Azab SR. Dexamethasone decreases the pro- to anti-inflammatory cytokine ratio during cardiac surgery. Br J Anaesthesia. 2002;88:496–501.CrossRef
28.
Jansen NJ, van Oeveren W, van den Broek L, Oudemans-Van Straate HM, Stoutenbeek CP, Joen MC, et al. Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1991;102:515–25.CrossRef
29.
Karaman K, Bostanci EB, Aksoy E, Ulas M, Yigit T, Erdemli MO, et al. Effects of dexamethasone and pheniramine hydrogen maleate on stress response in patients undergoing elective laparoscopic cholecystectomy. Am J Surg. 2013;205:213–9.CrossRef
30.
Kilger E, Weis FC, Goetz AE, Frey L, Kesel K, Schütz A, et al. Intensive care after minimally invasive and conventional coronary surgery: a prospective comparison. Intensive Care Med. 2001;27:534–9.CrossRef
31.
Harris DN, Bailey SM, Smith PL, Taylor KM, Oatridge A, Bydder GM. Brain swelling in first hour after coronary artery bypass surgery. Lancet. 1993;342:586–7.CrossRef
32.
Kaukonen K-M, Bailey M, Egi M, Orford N, Glassford NJ, Marik PE, et al. Stress hyperlactatemia modifies the relationship between stress hyperglycemia and outcome: a retrospective observational study. Crit Care Med. 2014;42:1379–85.CrossRef
Metadata
Title
Effect of high-dose dexamethasone on perioperative lactate levels and glucose control: a randomized controlled trial
Authors
Thomas H Ottens
Maarten WN Nijsten
Jan Hofland
Jan M Dieleman
Miriam Hoekstra
Diederik van Dijk
Joost MAA van der Maaten
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2015
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-015-0736-9

Other articles of this Issue 1/2015

Critical Care 1/2015 Go to the issue

Research

Mitochondrial function in skeletal muscle of patients with protracted critical illness and ICU-acquired weakness

Commentary

Is critical care ready for an economic surrogate endpoint?

Research

Diminished adrenal sensitivity to endogenous and exogenous adrenocorticotropic hormone in critical illness: a prospective cohort study

Research

Enteral glutamine supplementation in critically ill patients: a systematic review and meta-analysis

Research

Subarachnoid hemorrhage: who dies, and why?

Research

Association between the TLR2 Arg753Gln polymorphism and the risk of sepsis: a meta-analysis